|
![]() |
|||
|
||||
OverviewEdited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities. Full Product DetailsAuthor: John J Cush (Chief, Rheumatology and Clinical Immunology, Presbyterian Hospital of Dallas<br>Clinical Professor of Internal Medicine,) , Kathryn H. DaoPublisher: Elsevier Health Sciences Imprint: W B Saunders Co Ltd Volume: 38-4 Dimensions: Width: 15.20cm , Height: 1.30cm , Length: 22.90cm Weight: 0.460kg ISBN: 9781455750658ISBN 10: 1455750654 Pages: 240 Publication Date: 19 November 2012 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |